Mimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
Teva Pharmaceuticals USA is recalling Mimvey (estradiol and norethindrone acetate) tablets nationwide due to mislabeling on certain cartons. The recall affects 218,174 cartons distributed in the United States.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall for mislabeling, a packaging-only/labeling issue with no reported safety hazard or potential for direct harm to patients. Per the rubric, labeling errors without contamination or structural defects are classified as Low severity.
Plain-English summary
Teva Pharmaceuticals USA is recalling Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 tablets. The affected product has NDC 0093-5455-28 and was distributed nationwide. The recall was initiated on January 7, 2022, and terminated on June 1, 2023.
The reason for the recall is mislabeling on the cartons. Four specific lot numbers are affected: Lot 100018611 (expiration 03/2022), Lot 100019834 (expiration 06/2022), Lot 100022226 (expiration 09/2022), and Lot 100024574 (expiration 01/2023). A total of 218,174 cartons were distributed.
This is a voluntary recall initiated by the manufacturer. Teva Pharmaceuticals USA notified firms of the recall by letter. Consumers or healthcare providers who have this product should contact their pharmacy or healthcare provider for guidance on replacement or disposal.
The recalled product
- Product
- MIMVEY (ESTRADIOL AND NORETHINDRONE ACETATE)
- Brand
- MIMVEY
- Manufacturer
- Teva Pharmaceuticals USA
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot#: 100018611
- Exp 03/2022
- 100019834
- Exp 06/2022
- 100022226
- Exp 09/2022
- 100024574
- Exp 01/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · MIMVEY
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27